Abstract
The synthesis and SAR of a series of novel pyrazolo-quinazolines as potent and selective MPS1 inhibitors are reported. We describe the optimization of the initial hit, identified by screening the internal library collection, into an orally available, potent and selective MPS1 inhibitor.
Copyright © 2011 Elsevier Ltd. All rights reserved.
MeSH terms
-
Administration, Oral
-
Amides / chemical synthesis
-
Amides / chemistry*
-
Amides / pharmacokinetics
-
Animals
-
Cell Cycle Proteins / antagonists & inhibitors*
-
Cell Cycle Proteins / metabolism
-
Mice
-
Protein Kinase Inhibitors / chemical synthesis*
-
Protein Kinase Inhibitors / chemistry
-
Protein Kinase Inhibitors / pharmacokinetics
-
Protein Serine-Threonine Kinases / antagonists & inhibitors*
-
Protein Serine-Threonine Kinases / metabolism
-
Protein-Tyrosine Kinases
-
Quinazolines / chemistry*
-
Structure-Activity Relationship
Substances
-
Amides
-
Cell Cycle Proteins
-
Protein Kinase Inhibitors
-
Quinazolines
-
Protein-Tyrosine Kinases
-
Protein Serine-Threonine Kinases
-
TTK protein, human